Advertisement
RYTM vs TSHA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTM is a StrongBuy and TSHA is a StrongBuy.
RYTM in upward trend: price may jump up because it broke its lower Bollinger Band on October 07, 2026
RYTM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 28 of 31 cases where RYTM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RYTM's RSI Oscillator exited the oversold zone, 14 of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 54 cases where RYTM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on RYTM as a result. In 64 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
The Moving Average Convergence Divergence (MACD) for RYTM just turned positive on October 20, 2026. Looking at past instances where RYTM's MACD turned positive, the stock continued to rise in 40 of 50 cases over the following month. The odds of a continued upward trend are 80%.
Following a +3.26% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYTM advanced for three days, in 236 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYTM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
The Aroon Indicator for RYTM entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 22 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. RYTM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYTM's P/B Ratio (61.629) is slightly higher than the industry average of (2.974). P/E Ratio (-29.545) is within average values for comparable stocks, (-0.899). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.903) among similar stocks. P/S Ratio (27.548) is also within normal values, averaging (439.237).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
TSHA's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for TSHA turned positive on October 21, 2026. Looking at past instances where TSHA's MACD turned positive, the stock continued to rise in 40 of 43 cases over the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TSHA's RSI Oscillator exited the oversold zone, 30 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 58 of 66 cases where TSHA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
Following a +4.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where TSHA advanced for three days, in 216 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
TSHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The 50-day moving average for TSHA moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TSHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for TSHA entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 22 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.374) is normal, around the industry mean (3.037). P/E Ratio (-9.780) is within average values for comparable stocks, (-1.223). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.883) among similar stocks. P/S Ratio (333.333) is also within normal values, averaging (439.237).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. TSHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TSHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
RYTM | TSHA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 8 | 19 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 22 Undervalued | |
PROFIT vs RISK RATING 1..100 | 22 | 100 | |
SMR RATING 1..100 | 100 | 98 | |
PRICE GROWTH RATING 1..100 | 62 | 81 | |
P/E GROWTH RATING 1..100 | 27 | 17 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TSHA's Valuation (22) in the null industry is significantly better than the same rating for RYTM (91) in the Biotechnology industry. This means that TSHA’s stock grew significantly faster than RYTM’s over the last 12 months.
RYTM's Profit vs Risk Rating (22) in the Biotechnology industry is significantly better than the same rating for TSHA (100) in the null industry. This means that RYTM’s stock grew significantly faster than TSHA’s over the last 12 months.
TSHA's SMR Rating (98) in the null industry is in the same range as RYTM (100) in the Biotechnology industry. This means that TSHA’s stock grew similarly to RYTM’s over the last 12 months.
RYTM's Price Growth Rating (62) in the Biotechnology industry is in the same range as TSHA (81) in the null industry. This means that RYTM’s stock grew similarly to TSHA’s over the last 12 months.
TSHA's P/E Growth Rating (17) in the null industry is in the same range as RYTM (27) in the Biotechnology industry. This means that TSHA’s stock grew similarly to RYTM’s over the last 12 months.
| RYTM | TSHA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 2 days ago 83% |
| Stochastic ODDS (%) | 1 day ago 89% | 2 days ago 88% |
| Momentum ODDS (%) | 1 day ago 85% | N/A |
| MACD ODDS (%) | 1 day ago 80% | 2 days ago 90% |
| TrendWeek ODDS (%) | 1 day ago 81% | 2 days ago 82% |
| TrendMonth ODDS (%) | 1 day ago 75% | 2 days ago 88% |
| Advances ODDS (%) | 1 day ago 80% | 7 days ago 82% |
| Declines ODDS (%) | 15 days ago 73% | 5 days ago 90% |
| BollingerBands ODDS (%) | 1 day ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 2 days ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RYTM’s FA Score shows that 2 FA rating(s) are green while TSHA’s FA Score has 2 green FA rating(s).
- RYTM’s FA Score: 2 green, 3 red.
- TSHA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RYTM’s TA Score shows that 6 TA indicator(s) are bullish while TSHA’s TA Score has 5 bullish TA indicator(s).
- RYTM’s TA Score: 6 bullish, 2 bearish.
- TSHA’s TA Score: 5 bullish, 3 bearish.
Price Growth
RYTM (@Biotechnology) experienced а +2.20% price change this week, while TSHA (@Biotechnology) price change was +1.78% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.36%. For the same industry, the average monthly price growth was -13.16%, and the average quarterly price growth was -14.28%.
Reported Earning Dates
RYTM is expected to report earnings on Nov 03, 2026.
TSHA is expected to report earnings on Nov 03, 2026.
Industries' Descriptions
@Biotechnology (-1.36% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
TSHA and
Correlation & Price change
A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with SLDB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then SLDB could also see price increases.
| Ticker / NAME | Correlation To TSHA | 1D Price Change % | ||
|---|---|---|---|---|
| TSHA | 100% | +1.26% | ||
| SLDB - TSHA | 53% Loosely correlated | -1.86% | ||
| STOK - TSHA | 52% Loosely correlated | +1.68% | ||
| ABEO - TSHA | 52% Loosely correlated | -2.05% | ||
| MGTX - TSHA | 51% Loosely correlated | -0.33% | ||
| NGNE - TSHA | 49% Loosely correlated | -0.04% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QYLG | 29.86 | 0.33 | +1.12% |
| Global X Nasdaq 100 Covered Call & Growth ETF (QYLG) | |||
| BRES | 26.12 | 0.28 | +1.07% |
| Burney U.S. Equity Select ETF (BRES) | |||
| EMES | 25.56 | 0.25 | +1.01% |
| Harbor Emerging Markets Select ETF (EMES) | |||
| CDIG | 25.37 | 0.23 | +0.93% |
| City Different Investments Global Equity ETF (CDIG) | |||
| JMST | 50.94 | 0.01 | +0.02% |
| JPMorgan Ultra-Short Municipal Income ETF (JMST) | |||